Discovery of Antimicrobial Peptides in Urinary Tract Infections
European Urology Focus · 2024-09 · 10 (5) · 710-712
DOI: 10.1016/j.euf.2024.08.010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Urology Focus, 2024-09. Verfasst von Hannah Voss und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental Immunology and Imaging, University Hospital Essen, University Duisburg-Essen, Essen, Germany. Hauptthemen laut MEDLINE: Urinary Tract Infections, Antimicrobial Peptides. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, University of Duisburg-Essen.
Abstract (Originalsprache)
Antimicrobial peptides (AMPs) play a pivotal role in the innate immune system as a frontline defense against microbial threats. AMPs can serve as biomarkers and alternative antibiotics, overcoming mortality related to multidrug-resistant pathogens in urinary tract infections (UTIs). While the relevance of AMPs in UTIs has been validated and AMP drugs approved by the US Food and Drug Administration are in clinical use, information about their modification status, regulation, and mechanism of action remains sparse. Only a small fraction of sequences with potential AMP activity, predicted on the basis of known AMP characteristics, have been validated. Elucidation of the global profile of AMPs in the bladder, kidney, and urine under UTI conditions would facilitate an in-depth, disease-specific understanding of the innate immune system and the development of tailored AMP biomarkers and antibiotics. This mini-review focuses on a comprehensive strategy for global profiling and validation of AMPs in UTIs that incorporates AMP data repositories, prediction algorithms, and proteomics for healthy individuals and UTI patients. PATIENT SUMMARY: Short protein molecules called peptides that have antimicrobial activity show promise for the treatment of urinary tract infections. More research and testing of naturally occurring and synthetic peptides with this activity are needed to fully understand how they can help in patient care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Experimental Immunology and Imaging, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
- Clinic for Urology, Paediatric Urology and Andrology, Justus-Liebig University Giessen, Giessen, Germany.
- Institute of Experimental Immunology and Imaging, University Hospital Essen, University Duisburg-Essen, Essen, Germany. Electronic address: olga.shevchuk@uk-essen.de.
Förderung
- Deutsche Forschungsgemeinschaft
- University of Duisburg-Essen
Zitieren
APA
Voss, H., Robert Engel, D., Wagenlehner, F., & Shevchuk, O. (2024). Discovery of Antimicrobial Peptides in Urinary Tract Infections. European Urology Focus, 10(5), 710-712. https://doi.org/10.1016/j.euf.2024.08.010
Vancouver
Voss H, Robert Engel D, Wagenlehner F, Shevchuk O. Discovery of Antimicrobial Peptides in Urinary Tract Infections. European Urology Focus. 2024;10(5):710-712. doi:10.1016/j.euf.2024.08.010
BibTeX
@article{Voss2024,
author = {Voss, Hannah and Robert Engel, Daniel and Wagenlehner, Florian and Shevchuk, Olga},
title = {Discovery of Antimicrobial Peptides in Urinary Tract Infections},
journal = {European Urology Focus},
year = {2024},
volume = {10},
number = {5},
pages = {710--712},
doi = {10.1016/j.euf.2024.08.010}
}
EUVIMED